{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:15Z","timestamp":1753891935194,"version":"3.41.2"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Vestibulodynia (VBD) is the most common cause of sexual pain in the United States, affecting up to 15% of reproductive-aged women during their lifetime with limited treatment options. The purpose of this study was to describe ideal physical characteristics of a vulvar film designed for insertional sexual pain in sexually active women with VBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty women were recruited to participant in one of six, semi-structured 60-minute focus group discussions regarding treatment options for VBD. Heterosexual women, aged 18\u201351 years old with a diagnosis of vulvodynia, vestibulodynia or insertional dyspareunia fit the inclusion criteria. Those who reported no episodes of vaginal intercourse in the prior 18 months were excluded. A new vulvar film technology loaded with 50\u2005mg of 5% lidocaine was introduced to the group. Participants took part in focus groups on a rolling basis depending on availability. Focus group discussions were audio-recorded and transcribed verbatim. Two study investigators coded the transcripts using inductive coding and merged their respective projects to resolve disagreements. We analyzed data related to each code to develop code clusters and higher-level primary topics regarding device preferences. Data related to each of these primary topics was analyzed to assess the range of participant attitudes and preferences and to identify patterns within each primary topic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and sixteen women were recruited, and twenty women were enrolled. The mean age for the participants was 33.3 years. Most women were educated with at least some college (93%), White (78.6%), married (75%), and had income greater than $100,000 (50%). Analysis of the focus group discussions identified five common topics addressed by participants: desired loaded medication, film size, film shape, film flexibility, and ease and accuracy of use. Concerns across topics included comfort, sexual spontaneity, and efficacy. Interest in loading the device with other acceptable medications or combination with lidocaine was independently noted in 2\/6 (33%) of the focus groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Mucoadhesive vulvar thin films may be an acceptable drug delivery system for insertional sexual pain for women with VBD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpain.2023.1217035","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T07:49:02Z","timestamp":1695109742000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Preferred physical characteristics of lidocaine thin film for women with vestibulodynia"],"prefix":"10.3389","volume":"4","author":[{"given":"R. Gina","family":"Silverstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha Grace","family":"Cromeens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Ogbansiegbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Mihas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Rahima","family":"Benhabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin T.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"B1","first-page":"82","article-title":"A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia?","volume":"58","author":"Harlow","year":"1972","journal-title":"J Am Med Womens Assoc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41572-020-0164-2","article-title":"Vulvodynia","volume":"6","author":"Bergeron","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/j.pain.0000000000000789","article-title":"Clinical assessment of the impact of pelvic pain on women","volume":"158","author":"Chalmers","year":"2017","journal-title":"Pain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1185\/03007995.2012.666963","article-title":"Economic burden and quality of life of vulvodynia in the United States","volume":"28","author":"Xie","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"B5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/GRF.0000000000000576","article-title":"Vulvodynia","volume":"63","author":"Barnabei","year":"2020","journal-title":"Clin Obstet Gynecol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejogrb.2017.10.026","article-title":"Generalized unprovoked vulvodynia: a retrospective study on the efficacy of treatment with amitriptyline, gabapentin or pregabalin","volume":"220","author":"van Beekhuizen","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/01.lgt.0000225899.75207.0a","article-title":"Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors","volume":"10","author":"Reed","year":"2006","journal-title":"J Low Genit Tract Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2018.10.021","article-title":"Effect of gabapentin on sexual function in vulvodynia: a randomized, placebo-controlled trial","volume":"220","author":"Bachmann","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3109\/00016349.2010.512071","article-title":"Surgical treatment of vulvar vestibulitis: a review","volume":"89","author":"Tommola","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/13625187.2019.1643835","article-title":"Systematic review and meta-analysis of the effects of treatment modalities for vestibulodynia in women","volume":"24","author":"P\u00e9rez-L\u00f3pez","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jsxm.2022.02.008","article-title":"Treatment of provoked vulvodynia: a systematic review","volume":"19","author":"Bohm-Starke","year":"2022","journal-title":"J Sex Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0277-9536(00)00162-3","article-title":"Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda","volume":"52","author":"Green","year":"2001","journal-title":"Soc Sci Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1089\/jwh.2010.2476","article-title":"Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women","volume":"20","author":"Nel","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/jps.23577","article-title":"Vaginal films for drug delivery","volume":"102","author":"Machado","year":"2013","journal-title":"J Pharm Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10508-016-0816-1","article-title":"Preferred physical characteristics of vaginal film microbicides for HIV prevention in Pittsburgh women","volume":"46","author":"Fan","year":"2017","journal-title":"Arch Sex Behav"},{"key":"B16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/QAI.0000000000000897","article-title":"A phase 1 trial to assess the safety, acceptability, pharmacokinetics, and pharmacodynamics of a novel dapivirine vaginal film","volume":"71","author":"Bunge","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"121288","DOI":"10.1016\/j.ijpharm.2021.121288","article-title":"A mucoadhesive biodissolvable thin film for localized and rapid delivery of lidocaine for the treatment of vestibulodynia","volume":"612","author":"Dahl","year":"2022","journal-title":"Int J Pharm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00404-019-05212-x","article-title":"Current usage of qualitative research in female pelvic pain: a systematic review","volume":"300","author":"Mellado","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1001\/jama.284.3.357","article-title":"Users\u2019 guides to the medical literature: XXIII. Qualitative research in health care A. Are the results of the study valid? Evidence-based medicine working group","volume":"284","author":"Giacomini","year":"2000","journal-title":"JAMA"},{"year":"","author":"Kamberelis","key":"B20"},{"volume-title":"Qualitative research & evaluation methods: Integrating theory and practice\u2014michael quinn patton\u2014google books","year":"2015","author":"Patton","key":"B21"},{"volume-title":"The coding manual for qualitative researchers","year":"2021","author":"Salda\u00f1a","key":"B22"},{"article-title":"Doing qualitative research","year":"2023","author":"Crabtree","key":"B23"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jmwh.13456","article-title":"Evaluation and treatment of vulvodynia: state of the science","volume":"68","author":"Schlaeger","year":"2023","journal-title":"J Midwifery Womens Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jsxm.2018.03.003","article-title":"Patterns in vulvodynia treatments and 6-month outcomes for women enrolled in the national vulvodynia registry-an exploratory prospective study","volume":"15","author":"Lamvu","year":"2018","journal-title":"J Sex Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/LGT.0000000000000605","article-title":"Comparing vestibule examination techniques: light touch, serial forces, and the lidocaine test","volume":"25","author":"Stenson","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0029-7844(03)00368-5","article-title":"Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis","volume":"102","author":"Zolnoun","year":"2003","journal-title":"Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41443-022-00537-9","article-title":"Exclusive manual perineal rehabilitation with lidocaine 2% gel in the treatment of provoked vestibulodynia: results from a single-arm interventional study","volume":"35","author":"Close","year":"2023","journal-title":"Int J Impot Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1016\/j.jsxm.2016.04.011","article-title":"011 Efficacy of multimodal physiotherapy treatment compared to overnight topical lidocaine in women with provoked vestibulodynia: a bi-center randomized controlled trial","volume":"13","author":"Morin","year":"2016","journal-title":"J Sex Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3109\/10717544.2014.928760","article-title":"Advanced topical drug delivery system for the management of vaginal candidiasis","volume":"23","author":"Johal","year":"2016","journal-title":"Drug Deliv"},{"key":"B31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.addr.2015.02.001","article-title":"Mucoadhesive and thermogelling systems for vaginal drug delivery","volume":"92","author":"Caramella","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"16094069221105075","DOI":"10.1177\/16094069221105075","article-title":"From challenge to opportunity: virtual qualitative research during COVID-19 and beyond","volume":"21","author":"Keen","year":"2022","journal-title":"Int J Qual Methods"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2023.1217035\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T07:49:05Z","timestamp":1695109745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2023.1217035\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":32,"alternative-id":["10.3389\/fpain.2023.1217035"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2023.1217035","relation":{},"ISSN":["2673-561X"],"issn-type":[{"type":"electronic","value":"2673-561X"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"article-number":"1217035"}}